Alector (ALEC) Competitors $2.35 -0.04 (-1.67%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.35 0.00 (-0.21%) As of 08/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALEC vs. CRON, VERV, VALN, NUVB, MLYS, ATAI, IOVA, UPB, ORIC, and PHARShould you be buying Alector stock or one of its competitors? The main competitors of Alector include Cronos Group (CRON), Verve Therapeutics (VERV), Valneva (VALN), Nuvation Bio (NUVB), Mineralys Therapeutics (MLYS), atai Life Sciences (ATAI), Iovance Biotherapeutics (IOVA), Upstream Bio (UPB), Oric Pharmaceuticals (ORIC), and Pharming Group (PHAR). These companies are all part of the "pharmaceutical products" industry. Alector vs. Its Competitors Cronos Group Verve Therapeutics Valneva Nuvation Bio Mineralys Therapeutics atai Life Sciences Iovance Biotherapeutics Upstream Bio Oric Pharmaceuticals Pharming Group Alector (NASDAQ:ALEC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings. Which has more volatility & risk, ALEC or CRON? Alector has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Do analysts prefer ALEC or CRON? Alector currently has a consensus target price of $4.17, suggesting a potential upside of 77.30%. Given Alector's stronger consensus rating and higher probable upside, equities research analysts plainly believe Alector is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alector 2 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.29Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ALEC or CRON more profitable? Cronos Group has a net margin of 14.19% compared to Alector's net margin of -142.10%. Cronos Group's return on equity of -3.78% beat Alector's return on equity.Company Net Margins Return on Equity Return on Assets Alector-142.10% -112.06% -26.37% Cronos Group 14.19%-3.78%-3.62% Do institutionals & insiders have more ownership in ALEC or CRON? 85.8% of Alector shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 9.7% of Alector shares are held by insiders. Comparatively, 7.3% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to ALEC or CRON? In the previous week, Cronos Group had 3 more articles in the media than Alector. MarketBeat recorded 8 mentions for Cronos Group and 5 mentions for Alector. Alector's average media sentiment score of 0.79 beat Cronos Group's score of 0.57 indicating that Alector is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alector 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, ALEC or CRON? Cronos Group has higher revenue and earnings than Alector. Alector is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlector$100.56M2.37-$119.05M-$1.16-2.03Cronos Group$117.61M8.47$41.08M$0.0552.00 SummaryCronos Group beats Alector on 9 of the 15 factors compared between the two stocks. Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALEC vs. The Competition Export to ExcelMetricAlectorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$237.85M$3.09B$5.72B$9.84BDividend YieldN/A2.28%4.10%4.04%P/E RatioN/A7.3462.5426.61Price / Sales2.37392.01536.98176.28Price / CashN/A44.2237.4459.65Price / Book3.368.0710.556.59Net Income-$119.05M-$53.98M$3.27B$266.12M7 Day Performance-6.75%-0.88%0.41%0.16%1 Month Performance46.88%6.20%5.91%3.02%1 Year Performance-55.49%7.13%48.06%19.66% Alector Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALECAlector3.9246 of 5 stars$2.35-1.7%$4.17+77.3%-55.0%$237.85M$100.56M0.00270News CoverageCRONCronos Group0.9295 of 5 stars$2.60+1.6%N/A+18.2%$995.90M$117.61M52.00450Analyst UpgradeVERVVerve Therapeutics2.0138 of 5 stars$11.13flat$14.57+30.9%N/A$992.13M$32.33M-5.27110VALNValneva1.9921 of 5 stars$11.64+4.0%$16.00+37.5%+20.6%$990.45M$183.52M-11.88700Gap UpNUVBNuvation Bio2.3098 of 5 stars$2.89+5.5%$7.33+153.6%-6.9%$989.85M$7.87M-4.5960News CoverageMLYSMineralys Therapeutics3.0715 of 5 stars$14.89+1.9%$32.25+116.6%+23.2%$987.13MN/A-4.1828News CoverageAnalyst ForecastATAIatai Life Sciences3.3982 of 5 stars$4.57+4.1%$11.25+146.2%+252.3%$979.53M$310K-6.6280Gap UpHigh Trading VolumeIOVAIovance Biotherapeutics4.545 of 5 stars$2.69+5.9%$11.90+342.4%-80.4%$973.39M$241.53M-2.19500UPBUpstream Bio2.5494 of 5 stars$17.63-0.6%$56.50+220.5%N/A$950.43M$2.37M0.0038News CoveragePositive NewsORICOric Pharmaceuticals4.7359 of 5 stars$9.74+0.5%$17.63+81.0%+0.3%$945.95MN/A-5.1580PHARPharming Group2.3466 of 5 stars$13.70+8.2%$30.00+119.0%+88.6%$938.59M$297.20M-105.38280Gap UpHigh Trading Volume Related Companies and Tools Related Companies Cronos Group Alternatives Verve Therapeutics Alternatives Valneva Alternatives Nuvation Bio Alternatives Mineralys Therapeutics Alternatives atai Life Sciences Alternatives Iovance Biotherapeutics Alternatives Upstream Bio Alternatives Oric Pharmaceuticals Alternatives Pharming Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALEC) was last updated on 8/30/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
